BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 38440438)

  • 1. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
    Fatima S; Ahmed A; Suleman S; Din NU
    Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhage of MRI and Immunohistochemical Panels Distinguish Secretory Carcinoma From Acinic Cell Carcinoma.
    Kuwabara H; Yamamoto K; Terada T; Kawata R; Nagao T; Hirose Y
    Laryngoscope Investig Otolaryngol; 2018 Aug; 3(4):268-274. PubMed ID: 30186957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
    Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
    Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity.
    Skalova A
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S30-6. PubMed ID: 23821207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Utility of Expression Pattern of S100/Mammaglobin/SOX10/DOG 1 Immunohistochemistry in Differentiation of Secretory and Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Sharma G; Kamboj M; Narwal A; Keerthika R; Devi A; Vijayakumar G
    Indian J Otolaryngol Head Neck Surg; 2024 Feb; 76(1):208-218. PubMed ID: 38440438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
    Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
    Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E
    J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review.
    Sharma P; Sivakumar N; Pandiar D
    J Oral Pathol Med; 2023 Mar; 52(3):255-262. PubMed ID: 36207812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTRK3 mutation in secretory carcinoma of the parotid gland: A Case report.
    AlKaabba F; Alloghbi A; Deajim Y; Sukkari MW; Khan MYA; Sukari A
    Clin Case Rep; 2022 Sep; 10(9):e6243. PubMed ID: 36093449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zymogen-poor acinic cell carcinoma of the soft palate with high-grade transformation.
    Kallarakkal TG; Ismail SM; Goh YC
    Malays J Pathol; 2022 Apr; 44(1):121-127. PubMed ID: 35484895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.
    Wiles AB; Gabrielson M; Baloch ZW; Faquin WC; Jo VY; Callegari F; Kholova I; Song S; Centeno BA; Ali SZ; Tommola S; Fadda G; Petrone G; Wang H; Rossi ED; Pantanowitz L; Maleki Z
    Cancer Cytopathol; 2022 Sep; 130(9):684-694. PubMed ID: 35385604
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.